Renato Mantegazza Selected Research

Encephalitis (Encephalitis, Rasmussen)

1/2023	Autoimmunity to neuronal nicotinic acetylcholine receptors.
10/2002	Antibodies against GluR3 peptides are not specific for Rasmussen's encephalitis but are also present in epilepsy patients with severe, early onset disease and intractable seizures.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Renato Mantegazza Research Topics

Disease

64	Myasthenia Gravis 02/2024 - 01/2002
10	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 03/2021 - 11/2002
9	Thymoma (Thymic Carcinoma) 02/2023 - 07/2005
9	Inflammation (Inflammations) 01/2020 - 09/2003
8	Fibrosis (Cirrhosis) 12/2018 - 11/2002
8	Muscular Dystrophies (Muscular Dystrophy) 01/2018 - 11/2002
7	Multiple Sclerosis 02/2022 - 12/2003
6	Autoimmune Diseases (Autoimmune Disease) 01/2024 - 02/2008
6	Experimental Autoimmune Myasthenia Gravis (Autoimmune Experimental Myasthenia Gravis) 01/2019 - 09/2003
4	Muscle Weakness 01/2024 - 01/2021
4	Muscular Diseases (Myopathy) 11/2023 - 05/2010
4	Neoplasms (Cancer) 02/2023 - 08/2009
4	Thymus Hyperplasia 02/2023 - 08/2003
4	Neuromuscular Diseases (Neuromuscular Disease) 02/2023 - 11/2005
4	Infections 01/2023 - 01/2018
4	Fatigue 01/2022 - 01/2018
4	Spinal Muscular Atrophy (Progressive Muscular Atrophy) 01/2022 - 01/2019
4	Disease Progression 05/2021 - 01/2006
4	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2016 - 10/2009
3	COVID-19 01/2023 - 01/2022
3	Congenital Myasthenic Syndromes (Myasthenia Gravis, Congenital) 01/2023 - 07/2010
3	Headache (Headaches) 01/2023 - 12/2017
3	Lambert-Eaton Myasthenic Syndrome (Lambert-Eaton Syndrome) 11/2019 - 09/2008
3	Inclusion Body Myositis 01/2018 - 10/2011
3	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 09/2013 - 01/2006
2	Rare Diseases (Rare Disease) 10/2023 - 01/2023
2	Body Weight (Weight, Body) 08/2023 - 06/2023
2	Meningococcal Infections 08/2023 - 01/2019
2	Hyperplasia 02/2023 - 07/2005
2	Fever (Fevers) 01/2023 - 01/2022
2	Encephalitis (Encephalitis, Rasmussen) 01/2023 - 10/2002
2	Nervous System Diseases (Neurological Disorders) 01/2023 - 08/2019
2	Neuromuscular Junction Diseases 01/2022 - 09/2017
2	Pain (Aches) 01/2022 - 05/2013
2	Channelopathies 01/2021 - 10/2016
2	Glycogen Storage Disease Type II (Pompe's Disease) 01/2021 - 01/2020
2	Laminopathies 01/2020 - 01/2018
2	Inborn Genetic Diseases (Disease, Hereditary) 03/2019 - 09/2013
2	Myotonia 01/2019 - 09/2013
2	Necrosis 12/2018 - 12/2011
2	Myotonia Congenita (Thomsen Disease) 10/2016 - 09/2013
2	Epstein-Barr Virus Infections 04/2016 - 01/2011
2	Limb-Girdle Muscular Dystrophies (Limb-Girdle Muscular Dystrophy) 05/2014 - 11/2005

Drug/Important Bio-Agent (IBA)

22	Cholinergic ReceptorsIBA 02/2024 - 02/2004
20	Proteins (Proteins, Gene)FDA Link 02/2023 - 11/2002
18	AutoantibodiesIBA 01/2024 - 04/2004
18	AntibodiesIBA 02/2023 - 10/2002
11	glucose-mannose-glucoseIBA 02/2024 - 01/2019
11	Biomarkers (Surrogate Marker)IBA 11/2023 - 06/2013
9	MicroRNAs (MicroRNA)IBA 02/2023 - 01/2015
8	Immunoglobulin G (IgG)IBA 01/2024 - 09/2008
8	Toll-Like Receptors (Toll-Like Receptor)IBA 11/2023 - 07/2005
7	ravulizumabIBA 02/2024 - 05/2022
7	Peptides (Polypeptides)IBA 01/2023 - 10/2002
7	Messenger RNA (mRNA)IBA 01/2023 - 11/2002
7	eculizumab FDA Link 01/2021 - 12/2017
6	Phosphotransferases (Kinase)IBA 01/2023 - 08/2008
6	CollagenIBA 12/2018 - 11/2002
5	Immunosuppressive Agents (Immunosuppressants)IBA 02/2022 - 02/2008
5	CytokinesIBA 01/2022 - 11/2002
4	Complement Inactivating AgentsIBA 10/2023 - 12/2017
4	Cholinesterase Inhibitors (Anticholinesterases)IBA 05/2021 - 08/2003
4	AmifampridineIBA 01/2021 - 12/2015
4	Transforming Growth Factor beta1 (TGF beta 1)IBA 06/2006 - 11/2002
3	ConnectinIBA 02/2023 - 01/2023
3	AntigensIBA 01/2023 - 04/2008
3	muskIBA 01/2023 - 08/2008
3	Complement System Proteins (Complement)IBA 06/2022 - 12/2017
3	EnzymesIBA 01/2021 - 01/2017
3	Interleukin-4 (Interleukin 4)IBA 01/2020 - 04/2009
2	FM19G11IBA 03/2024 - 01/2019
2	zilucoplanIBA 01/2024 - 01/2023
2	Pyridostigmine Bromide (Pyridostigmine)FDA LinkGeneric 06/2023 - 10/2011
2	AutoantigensIBA 02/2023 - 04/2009
2	neonatal Fc receptorIBA 01/2023 - 01/2019
2	Intravenous Immunoglobulins (IVIG)FDA Link 01/2023 - 12/2017
2	Rituximab (Mabthera)FDA Link 01/2023 - 12/2017
2	VaccinesIBA 02/2022 - 01/2022
2	nusinersenIBA 01/2022 - 11/2020
2	SteroidsIBA 05/2021 - 05/2013
2	Adrenal Cortex Hormones (Corticosteroids)IBA 05/2021 - 01/2020
2	Paclitaxel (Taxol)FDA LinkGeneric 05/2021 - 03/2015
2	Immunoglobulin Fc FragmentsIBA 01/2021 - 01/2019
2	GlucosidasesIBA 01/2021 - 01/2020
2	Therapeutic UsesIBA 01/2020 - 01/2019
2	Immunoglobulins (Immunoglobulin)IBA 01/2019 - 08/2009
2	Epstein-Barr virus encoded RNA 1IBA 11/2017 - 01/2011
2	DNA (Deoxyribonucleic Acid)IBA 11/2017 - 02/2008
2	Azathioprine (Imuran)FDA LinkGeneric 01/2017 - 01/2013
2	Extracellular Matrix ProteinsIBA 01/2016 - 12/2011
2	DystrophinIBA 05/2014 - 06/2006
2	Sarcoglycans (beta Sarcoglycan)IBA 05/2014 - 11/2005
2	DecorinIBA 05/2014 - 11/2005

Therapy/Procedure

19	Activities of Daily Living (ADL) 02/2024 - 11/2017
18	Therapeutics 01/2023 - 01/2011
6	Thymectomy 01/2018 - 08/2003
2	Immunotherapy 01/2020 - 03/2015
2	Precision Medicine 10/2019 - 10/2018
2	Plasma Exchange 12/2017 - 01/2009
2	Immunomodulation 12/2015 - 06/2006